Deposition and Clinical Impact of Inhaled Particles in the Lung.

Particles suspended in the air we breathe are deposited in the airways as a function of the properties of the particle itself (shape, size and hydration), inspiratory air flow, airway anatomy, breathing environment, and mucociliary clearance. The scientific study of the deposition of inhaled particles in the airways has been conducted using traditional mathematical models and imaging techniques with particle markers. In recent years, the integration of statistical and computer methods, giving rise to a new discipline called digital microfluidics, has led to significant advances. In routine clinical practice, these studies are of great use for optimizing inhaler devices in line with particular characteristics of the drug to be inhaled and the pathology of the patient.

• Publication year

  2023

• Venue

  Archivos de Bronconeumologia

• Publication date

  2023-02-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.arbres.2023.01.016PMID 36872211
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhaled Medicines: Past, Present, and Future

  2022cited by this paper
• Product Hopping in the Drug Industry - Lessons from Albuterol.

  2022cited by this paper
• Pulmonary drug delivery and retention: A computational study to identify plausible parameters based on a coupled airway-mucus flow model

  2020cited by this paper
• Modifying and Integrating in vitro and ex vivo Respiratory Models for Inhalation Drug Screening

  2020cited by this paper
• A Retrospective Study of the Effectiveness of the AeroChamber Plus® Flow-Vu® Antistatic Valved Holding Chamber for Asthma Control

  2017cited by this paper
• Systematic Review of Errors in Inhaler Use: Has Patient Technique Improved Over Time?

  2016cited by this paper
• Use of computational fluid dynamics in respiratory medicine.

  2015cited by this paper
• Nebulized therapy. SEPAR year.

  2014cited by this paper
• Computational Modeling of Aerosol Deposition in Respiratory Tract: A Review

  2009cited by this paper
• Mathematical Analysis of Particle Deposition in Human Lungs: An Improved Single Path Transport Model

  2007cited by this paper
• Two-Dimensional and Three-Dimensional Imaging Show Ciclesonide Has High Lung Deposition and Peripheral Distribution: A Nonrandomized Study in Healthy Volunteers

  2006cited by this paper
• [Guideline for the use of inhaled drugs. The Working Group of SEPAR: the Nursing Area of the Sociedad Española de Neumología y Cirugía Torácica].

  2000cited by this paper
• A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers.

  1999cited by this paper
• Pharmaceutical Dry Powder Aerosols: Correlation of Powder Properties with Dose Delivery and Implications for Pharmacodynamic Effect

  1999cited by this paper
• The science of nebulised drug delivery

  1997cited by this paper
• A Comparison of Lung Deposition Patterns Between Different Asthma Inhalers

  1995cited by this paper
• Human respiratory tract model for radiological protection. A report of a Task Group of the International Commission on Radiological Protection.

  1994cited by this paper
• Pharmacokinetic Optimisation of Asthma Treatment

  1994cited by this paper
• The place of Intal in paediatric practice.

  1989cited by this paper
• Aerosol deposition considerations in inhalation therapy.

  1985cited by this paper
• Therapeutic aerosols 1--physical and practical considerations.

  1983cited by this paper
• Beclomethasone Dipropionate: A New Steroid Aerosol for the Treatment of Allergic Asthma

  1972cited by this paper
• Salbutamol: a new, selective beta-adrenoceptive receptor stimulant.

  1969cited by this paper
• Aerosol deposition in the human respiratory tract. I. Experimental procedures and total deposition.

  1957cited by this paper

• Prediction of site-specific drug deposition via dry powder inhaler using non-invasive real-time particle emission signal monitoring system

  2026cites this paper
• Recent and future developments in inhaled formulations to overcome anti-bacterial drug resistance.

  2026cites this paper
• Tracing aerosols in the human airways: The hidden role of temperature gradients

  2026cites this paper
• Study on dust exposure levels and respiratory particle deposition patterns in workers in respirable dust environments

  2025cites this paper
• Exposure to polluted environments rich in inhalable aerosols: A study on transport and deposition patterns of aerosol particles in the human respiratory tract

  2025cites this paper
• Cigarette smoking decreases macrophage-dependent clearance to impact the biological effects of occupational and environmental particle exposures

  2025cites this paper
• Application of multiple-path particle dosimetry (MPPD) model in aged-specify schoolchildren airways exposed to ambient particulate matter in Malaysia

  2025cites this paper
• Nanostructured lipid carriers-loaded dry powder inhaler for pulmonary delivery of amphotericin B in treatment of allergic bronchopulmonary aspergillosis.

  2025cites this paper
• The Role of Particle Inhalation in Idiopathic Pulmonary Fibrosis

  2025cites this paper
• Particulate matter extracted from human anthracotic tissues induces inflammatory markers in co-culture of lung cells and macrophages.

  2025cites this paper
• Airborne particulate matter inhalation bioaccessibility: A review of methodological aspects.

  2025cites this paper
• Features of modern inhalation therapy and topical aerosol delivery

  2024cites this paper
• Drug Concentrations in the Air and their Influencing Factors in a Pediatric Intensive Care Unit

  2024cites this paper
• Design, development, and technical considerations for dry powder inhaler devices.

  2024cites this paper
• Applying new approach methodologies to assess next-generation tobacco and nicotine products

  2024cites this paper
• Efficient Nebulization and Pulmonary Biodistribution of Polymeric Nanocarriers in an Acute Lung Injury Preclinical Model

  2024cites this paper
• Study on the Effects of Dust Particle Size and Respiratory Intensity on the Pattern of Respiratory Particle Deposition in Humans

  2024cites this paper
• Inhalational Drug Devices: Revisiting the Linchpin of Asthma Management

  2024cites this paper
• Inhalational exposure to heavy metals: carcinogenic and non-carcinogenic risk assessment

  2024cites this paper
• Membrane Permeability and Drug Targeting Potential of Phospholipid‐Based Nanocarriers in Lung Cancer Therapy

  2024cites this paper
• Respiratory delivered vaccines: Current status and perspectives in rational formulation design

  2024cites this paper
• Neurocognitive assessment in microgravity: review of tools and benefits of increasing their clinical validity for long duration missions

  2023influential citation
• Emerging delivery approaches for targeted pulmonary fibrosis treatment.

  2023cites this paper
• Evaluation of Different Doses in Inhaled Therapy: A Comprehensive Analysis

  2023cites this paper